According to a market report, published by Sheer Analytics and Insights, the total global lab automation market was valued at $ 5.32 billion in 2021 and it is expected to reach $ 13.3 billion at a CAGR of 8.70% between 2022 and 2032. Lab automation works are commercial and government research, academics, scientists, and engineers who manage various researches and develop new technologies to increase productivity, decrease lab processing times, and allow experimentation that otherwise might be impossible. There are several key factors such as small volumes of reagents and samples required, progressing drug discovery, personnel safety, and miniaturization of the method thus leading to reduced reagent cost value, and clinical diagnosis. Therefore, the lab automation market is expected to witness a significant growth opportunity due to the increasing prevalence of infectious diseases and a rising number of tests performed in laboratories. Furthermore, pharmaceutical and biotechnology companies are focusing on investments in research to fulfill the needs of the healthcare sector. For example, few pharmaceutical companies such as Cipla, and Lupin limited, among others have made investments in R&D activities over the last couple of years. Moreover, collaboration between medical sectors stakeholders and pharmaceutical companies will increase the use of laboratories automation; hence these are expected to drive the demand for the lab automation market across the globe.
The demand for the application of automation is rising and this is one of the key factors which are expected to drive the growth of the market during the forecast period. For instance, lab automation has replaced clinical chemistry applications in several works such as power dosing, dilution of weight, solid-phase extraction, sample preparation analysis, safer working conditions for personnel in the laboratory, lower costs, and lesser laboratory space and times, and more. Along with these, other tasks such as the culture of the host organism, colony selection, final data, information collection, and fragment construction of DNA, have been replaced by laboratory automation processes. These have driven the market growth in the last few years.
Request a Sample Copy of Report: https://www.sheeranalyticsandinsights.com/request-sample/lab-automation-market-21
In addition, the launch of new lab automation solutions is anticipated to propel the growth of the market during the forecast period from 2022 to 2032. For instance, in 2020, UiPath has launched virtual streaming solutions for customers; COPAN Diagnostics established a new system called Radian automatic Kirby-Bauer susceptibility testing. However, there are few small and medium-sized laboratories that cannot adopt automation processes or solutions due to budget constraints and high services and maintenance costs. Even the cost of maintenance and services of an automation solution is higher than the main price of the software. Among all the regions, the market of North America held the largest revenue share in the last couple of years and the region is estimated to maintain its similar position over the forecast period.
According to the study, key players dominating the global lab automation market are PerkinElmer Corporation (U.S), Qiagen Company (Germany), Thermo Fisher Scientific Corporation (U.S), Danaher Corporation Company (U.S), Agilent Technologies Analytical laboratory Instrument manufacturing Company (U.S), Eppendorf Biotech Company (Germany), Hudson Robotics Inc. (U.S), Tecan Group Limited (Switzerland), BMG Labtech (Germany), Hamilton Company (U.S), Copan Innovation Limited Company (Italy), Abbott Laboratories Medical Device Company (U.S), Roche Holdings AG Pharmaceuticals Company (Switzerland), Novartis Pharmaceuticals Company (Switzerland), Pfizer Pharmaceutical Industry Company (U.S), Sanofi Pharmaceutical Industry Company (France), Synchron Lab Automation (Netherlands), Waters Corporation Analytical Laboratory Instrument Manufacturing Company (U.S), Peak Analysis and Automation (U.S), Institut Merieux Holding Company (France), Aurora Biomed Inc. Company (Canada), Formulatrix Inc. Company (U.S), Bio-Rad Laboratories (U.S), BD Medical Device Company (U.S), Hudson Robotics Inc. (U.S), among others.
The Global Lab Automation Market Has Been Segmented Into:
The Global Lab Automation Market – by Process:
- Discrete Processing
- Continuous Flow
The Global Lab Automation Market – by Type:
- Total Automation Systems
- Modular Automation Systems
The Global Lab Automation Market – by End-User:
- Electrolyte Analysis
- Immunoassay Analysis
- Clinical Chemistry Analysis
- Photometry
- Fluorometry
- And Others
The Global Lab Automation Market – by Regions:
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- Italy
- U.K.
- Russia
- Rest of Europe Countries
Asia-Pacific
- India
- China
- Japan
- South Korea
- North Korea
- Rest of Asian Countries
LAMEA
- Brazil
- Saudi Arabia
- Rest of LAME
Browse The Full Report at https://www.sheeranalyticsandinsights.com/market-report-research/lab-automation-market-21
About Us
Sheer Analytics and Insights Private Limited is market research, consulting, and IT services company. We as a company believe in providing point to point data and its analysis with the combination of our human and automation integration. Sheer Analytics and Insights cover majorly eight industry verticals, including chemicals, life science, communications, and electronics, materials, consumer goods, defense, and BFSI sector.
Sheer Analytics believes in quality work and ensures that the product delivered to the client is meaningful for them. We publish reports based on our advanced analytics reports, which are generated with the help of our in-house databases, external databases, and artificial intelligence integration processes. We stand out from other market research companies in terms of integrating facts with meaningful insights for forecasting.
Contact:
Abhigyan Sengupta
Sheer Analytics and Insights
Email: query@sheeranalyticsandinsights.com
+1-414-240-5010
No comments:
Post a Comment